Effective procurement of health products—medicines, diagnostics, and devices—is a foundational function for any health system and essential for progress toward the health-related Sustainable Development Goals. But a triple transition is on the horizon and global health procurement needs are evolving rapidly. Countries are transitioning from donor aid, global disease burdens are shifting from infectious to non-communicable conditions, and health systems are advancing from disease-specific programs to universal health coverage. CGD’s Working Group on the Future of Global Health Procurement reviewed evidence and formulated recommendations for how the global health community can achieve efficiencies and save lives through smarter health procurement in a changing world. You can read the full set of complementary fact sheets here:
To reassert itself as the global standard-setting body and better support modern and agile procurement policy and practice, the WHO should set and execute a prioritized guidance reform agenda.
It’s time for country governments and development partners to professionalize procurement as a core health system function.
In an evolving landscape, the global community should seek to sustain and possibly expand global cooperation for procurement—even after most countries transition from current global health mechanisms.
To help build a robust enabling environment for healthy generic competition, international technical bodies and national governments should ease barriers to quality generic entry.
Development partners should support governments to lead in-country reforms, helping ease institutional and legal barriers to effective procurement.
Read the full report here.